Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL (clinicaltrials.gov) - Sep 25, 2026 - P2 | N=61 | Completed | Sponsor: Hutchmed | Active, not recruiting ➔ Completed | Trial completion date: Nov 2026 ➔ May 2026
Trial completion • Trial completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|